Effect of clofibrate on aortic glycosaminoglycans and proteins and on serum lipid levels in experimental atherosclerosis

M. Bihari Varga, J. Fehér, M. Varsanyi, S. Gero

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The effect of clofibrate has been studied in cholesterol fed rabbits. A very highly significant reduction of the serum lipid level could be established after 2 weeks of clofibrate treatment. In the aorta of cholesterol fed rabbits a slight increase of glycosaminoglycan concentration and intensive lipid deposition was found by histological, histochemical and electronmicroscopical methods. By thermal analysis the presence of aortic glycosaminoglycan serum beta lipoprotein complexes and the accumulation of 'abnormal' crosslinks within the fibrillar tissue proteins could be demonstrated in the intima of the animals. As a result of clofibrate treatment a significantly increased glycosaminoglycan content was found in the aorta of rabbits with experimental atherosclerosis. At the same time a decrease could be established in the amount of aortic glycosaminoglycan beta lipoprotein complexes. The anti atherogenic action of clofibrate influenced the pathologically changed protein structure as well: the cholesterol induced alterations proved to be partly reversible.

Original languageEnglish
Pages (from-to)217-229
Number of pages13
JournalActa Medica Academiae Scientiarum Hungaricae
Volume29
Issue number3-4
Publication statusPublished - 1972

Fingerprint

Clofibrate
Glycosaminoglycans
Blood Proteins
Atherosclerosis
Lipids
Cholesterol
Rabbits
LDL Lipoproteins
Aorta
Serum
Proteins
Hot Temperature

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of clofibrate on aortic glycosaminoglycans and proteins and on serum lipid levels in experimental atherosclerosis. / Bihari Varga, M.; Fehér, J.; Varsanyi, M.; Gero, S.

In: Acta Medica Academiae Scientiarum Hungaricae, Vol. 29, No. 3-4, 1972, p. 217-229.

Research output: Contribution to journalArticle

@article{c8b23261dc1c4ea8beca27f3fea00660,
title = "Effect of clofibrate on aortic glycosaminoglycans and proteins and on serum lipid levels in experimental atherosclerosis",
abstract = "The effect of clofibrate has been studied in cholesterol fed rabbits. A very highly significant reduction of the serum lipid level could be established after 2 weeks of clofibrate treatment. In the aorta of cholesterol fed rabbits a slight increase of glycosaminoglycan concentration and intensive lipid deposition was found by histological, histochemical and electronmicroscopical methods. By thermal analysis the presence of aortic glycosaminoglycan serum beta lipoprotein complexes and the accumulation of 'abnormal' crosslinks within the fibrillar tissue proteins could be demonstrated in the intima of the animals. As a result of clofibrate treatment a significantly increased glycosaminoglycan content was found in the aorta of rabbits with experimental atherosclerosis. At the same time a decrease could be established in the amount of aortic glycosaminoglycan beta lipoprotein complexes. The anti atherogenic action of clofibrate influenced the pathologically changed protein structure as well: the cholesterol induced alterations proved to be partly reversible.",
author = "{Bihari Varga}, M. and J. Feh{\'e}r and M. Varsanyi and S. Gero",
year = "1972",
language = "English",
volume = "29",
pages = "217--229",
journal = "Acta Medica Academiae Scientiarum Hungaricae",
issn = "0001-5989",
publisher = "Akademiai Kiado",
number = "3-4",

}

TY - JOUR

T1 - Effect of clofibrate on aortic glycosaminoglycans and proteins and on serum lipid levels in experimental atherosclerosis

AU - Bihari Varga, M.

AU - Fehér, J.

AU - Varsanyi, M.

AU - Gero, S.

PY - 1972

Y1 - 1972

N2 - The effect of clofibrate has been studied in cholesterol fed rabbits. A very highly significant reduction of the serum lipid level could be established after 2 weeks of clofibrate treatment. In the aorta of cholesterol fed rabbits a slight increase of glycosaminoglycan concentration and intensive lipid deposition was found by histological, histochemical and electronmicroscopical methods. By thermal analysis the presence of aortic glycosaminoglycan serum beta lipoprotein complexes and the accumulation of 'abnormal' crosslinks within the fibrillar tissue proteins could be demonstrated in the intima of the animals. As a result of clofibrate treatment a significantly increased glycosaminoglycan content was found in the aorta of rabbits with experimental atherosclerosis. At the same time a decrease could be established in the amount of aortic glycosaminoglycan beta lipoprotein complexes. The anti atherogenic action of clofibrate influenced the pathologically changed protein structure as well: the cholesterol induced alterations proved to be partly reversible.

AB - The effect of clofibrate has been studied in cholesterol fed rabbits. A very highly significant reduction of the serum lipid level could be established after 2 weeks of clofibrate treatment. In the aorta of cholesterol fed rabbits a slight increase of glycosaminoglycan concentration and intensive lipid deposition was found by histological, histochemical and electronmicroscopical methods. By thermal analysis the presence of aortic glycosaminoglycan serum beta lipoprotein complexes and the accumulation of 'abnormal' crosslinks within the fibrillar tissue proteins could be demonstrated in the intima of the animals. As a result of clofibrate treatment a significantly increased glycosaminoglycan content was found in the aorta of rabbits with experimental atherosclerosis. At the same time a decrease could be established in the amount of aortic glycosaminoglycan beta lipoprotein complexes. The anti atherogenic action of clofibrate influenced the pathologically changed protein structure as well: the cholesterol induced alterations proved to be partly reversible.

UR - http://www.scopus.com/inward/record.url?scp=0015471402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015471402&partnerID=8YFLogxK

M3 - Article

C2 - 4270563

AN - SCOPUS:0015471402

VL - 29

SP - 217

EP - 229

JO - Acta Medica Academiae Scientiarum Hungaricae

JF - Acta Medica Academiae Scientiarum Hungaricae

SN - 0001-5989

IS - 3-4

ER -